Screening

Researchers discover bronchospasms mechanisms using microdevice

26 August 2019 | By Victoria Rees (Drug Target Review)

A ‘bronchi-on-a-chip’ has been created by researchers to identify the processes of bronchospasms which could aid in respiratory disease therapies.

Organ-on-an-electronic-chip could be used in drug development

23 August 2019 | By Victoria Rees (Drug Target Review)

Researchers have created a new organoid model that can be used to study systems such as the heart and the effects of drugs on these cells.

Cyclisation reaction enables screening of macrocyclic compounds libraries

22 August 2019 | By Rachael Harper (Drug Target Review)

Libraries of more than 9,000 macrocyclic molecules below 1 KDa have been generated, small enough to cross cell membranes and reach targets.

Optofluidic chip platform developed for single molecule analysis

19 August 2019 | By Rachael Harper (Drug Target Review)

A new platform has enabled an unprecedented level of control over individual molecules and particles on a chip for high-throughput analysis.

New CRISPR technique could alter the way we look at brain diseases

16 August 2019 | By Fraser Owen (Drug Target Review)

Researchers may have fundamentally altered the way scientists study brain diseases with new CRISPR technology.

Experimental treatment slows prion disease

5 August 2019 | By Rachael Harper (Drug Target Review)

A new experiment has not only slowed the progression of the prion disease, scrapie, it also extended the lives of prion-infected mice

Molecular Devices introduces the FLIPR^® Penta system

2 August 2019 | By Molecular Devices

Molecular Devices, LLC, today announced the launch of the next generation of its FLIPR® Penta High-Throughput Cellular Screening System.

Motor neuron disease electrical signalling pathways mapped

1 August 2019 | By Victoria Rees (Drug Target Review)

A study has used EEG to investigate the neuron networks that act abnormally in the condition, providing a significant step in the search for treatments.

Newly discovered signal could lead to anti-cancer therapies

31 July 2019 | By Drug Target Review

Researchers have newly found that protein CD24 acts as a defensive signal and is used by cancer cells to protect themselves.

Application note: Monitoring Aggregation of Antibody-Drug Conjugates

30 July 2019 | By Enzo Life Sciences

Prediction of Aggregation Propensity and Monitoring of Aggregation of Antibody-Drug Conjugates (ADC).

Encouraging drug discovery and therapeutic targets for dementia

26 July 2019 | By Victoria Rees (Drug Target Review)

A review has been published by experts in neurodegeneration research, detailing six ways to improve dementia research. This article investigates one of these suggestions, focusing on how we can improve drug target identification.

Screening identifies gene which protects cells from Zika virus

26 July 2019 | By Victoria Rees (Drug Target Review)

Researchers used screening to discover genes that protect the body against the Zika virus, which could inform potential therapies against the virus.

Chemical synthesis and biological screening combined on chip

16 July 2019 | By Victoria Rees (Drug Target Review)

Researchers have developed a chip which facilitates and accelerates active substance production, characterisation and biological effectiveness.

Intellicyt iQue3 – Faster, Smarter Flow Cytometry

8 July 2019 | By IntelliCyt Corporation

This advanced flow cytometry platform is a complete instrument, reagents and software solution streamlined to rapidly generate results not just data.

Titian Software Ltd